Legis Daily

STOP Fentanyl Overdoses Act of 2023

USA118th CongressHR-3375| House 
| Updated: 5/19/2023
Ann M. Kuster

Ann M. Kuster

Democratic Representative

New Hampshire

Cosponsors (34)
Donald Norcross (Democratic)Nikema Williams (Democratic)Becca Balint (Democratic)Barbara Lee (Democratic)Lisa Blunt Rochester (Democratic)David J. Trone (Democratic)Chrissy Houlahan (Democratic)Terri A. Sewell (Democratic)Steven Horsford (Democratic)Jimmy Panetta (Democratic)Debbie Dingell (Democratic)Tony Cárdenas (Democratic)Andrea Salinas (Democratic)Paul Tonko (Democratic)Angie Craig (Democratic)Delia C. Ramirez (Democratic)Shri Thanedar (Democratic)Greg Stanton (Democratic)Al Green (Democratic)Don Bacon (Republican)Nikki Budzinski (Democratic)John B. Larson (Democratic)Hillary J. Scholten (Democratic)Morgan McGarvey (Democratic)Brittany Pettersen (Democratic)Sean Casten (Democratic)William R. Keating (Democratic)Rick Larsen (Democratic)Colin Z. Allred (Democratic)Lori Trahan (Democratic)Nanette Diaz Barragán (Democratic)Jason Crow (Democratic)Teresa Leger Fernandez (Democratic)Chellie Pingree (Democratic)

Health Subcommittee, Judiciary Committee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Support, Treatment, and Overdose Prevention of Fentanyl Overdoses Act of 2023 or the STOP Fentanyl Overdoses Act of 2023 This bill addresses data collection, treatment, harm reduction, and other issues related to substance misuse and addiction. It particularly focuses on opioids, fentanyl, and related substances. Specifically, the bill expands surveillance of fentanyl and related substances. This includes requiring a study on how to track overdoses by type of drug (including fentanyl) and awarding grants to states for collecting data about fentanyl-involved overdoses. The bill also provides for (1) training on detecting and handling fentanyl for law enforcement, and (2) grants for forensic laboratories to facilitate surveillance of controlled substances seized by law enforcement. Additionally, the bill establishes and modifies requirements to increase access to treatment and prevention services. For example, the Bureau of Prisons must make certain services, including medication-assisted treatments, available to individuals in its custody. The bill also establishes grants and requires other efforts to expand access to medications that temporarily reverse opioid overdoses (e.g., naloxone) and related harm reduction activities. Furthermore, the bill extends, subject to some conditions, liability protections for those who administer aid in an emergency (commonly known as Good Samaritan laws) to individuals who administer opioid overdose reversal drugs and to individuals who seek medical attention for themselves or on behalf of another for a drug overdose. The bill also requires multiple reports, including a report by the Department of State on foreign sources of certain drugs.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
May 16, 2023
Introduced in House
May 16, 2023
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
May 19, 2023
Referred to the Subcommittee on Health.
May 31, 2023

Latest Companion Bill Action

S 118-1785
Introduced in Senate
  • May 16, 2023
    Introduced in House


  • May 16, 2023
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • May 19, 2023
    Referred to the Subcommittee on Health.


  • May 31, 2023

    Latest Companion Bill Action

    S 118-1785
    Introduced in Senate

Health

Related Bills

  • HR 118-4005: Naloxone Affordability Act of 2023
Civil actions and liabilityCongressional oversightCorrectional facilities and imprisonmentCustoms enforcementDrug, alcohol, tobacco useDrug trafficking and controlled substancesFederal preemptionGovernment information and archivesGovernment studies and investigationsHealth care costs and insuranceHealth care coverage and accessHealth information and medical recordsHealth promotion and preventive careIntelligence activities, surveillance, classified informationIntergovernmental relationsLaw enforcement administration and fundingMedical researchMental healthResearch administration and fundingRetail and wholesale tradesSmuggling and traffickingState and local government operations

STOP Fentanyl Overdoses Act of 2023

USA118th CongressHR-3375| House 
| Updated: 5/19/2023
Support, Treatment, and Overdose Prevention of Fentanyl Overdoses Act of 2023 or the STOP Fentanyl Overdoses Act of 2023 This bill addresses data collection, treatment, harm reduction, and other issues related to substance misuse and addiction. It particularly focuses on opioids, fentanyl, and related substances. Specifically, the bill expands surveillance of fentanyl and related substances. This includes requiring a study on how to track overdoses by type of drug (including fentanyl) and awarding grants to states for collecting data about fentanyl-involved overdoses. The bill also provides for (1) training on detecting and handling fentanyl for law enforcement, and (2) grants for forensic laboratories to facilitate surveillance of controlled substances seized by law enforcement. Additionally, the bill establishes and modifies requirements to increase access to treatment and prevention services. For example, the Bureau of Prisons must make certain services, including medication-assisted treatments, available to individuals in its custody. The bill also establishes grants and requires other efforts to expand access to medications that temporarily reverse opioid overdoses (e.g., naloxone) and related harm reduction activities. Furthermore, the bill extends, subject to some conditions, liability protections for those who administer aid in an emergency (commonly known as Good Samaritan laws) to individuals who administer opioid overdose reversal drugs and to individuals who seek medical attention for themselves or on behalf of another for a drug overdose. The bill also requires multiple reports, including a report by the Department of State on foreign sources of certain drugs.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
May 16, 2023
Introduced in House
May 16, 2023
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
May 19, 2023
Referred to the Subcommittee on Health.
May 31, 2023

Latest Companion Bill Action

S 118-1785
Introduced in Senate
  • May 16, 2023
    Introduced in House


  • May 16, 2023
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • May 19, 2023
    Referred to the Subcommittee on Health.


  • May 31, 2023

    Latest Companion Bill Action

    S 118-1785
    Introduced in Senate
Ann M. Kuster

Ann M. Kuster

Democratic Representative

New Hampshire

Cosponsors (34)
Donald Norcross (Democratic)Nikema Williams (Democratic)Becca Balint (Democratic)Barbara Lee (Democratic)Lisa Blunt Rochester (Democratic)David J. Trone (Democratic)Chrissy Houlahan (Democratic)Terri A. Sewell (Democratic)Steven Horsford (Democratic)Jimmy Panetta (Democratic)Debbie Dingell (Democratic)Tony Cárdenas (Democratic)Andrea Salinas (Democratic)Paul Tonko (Democratic)Angie Craig (Democratic)Delia C. Ramirez (Democratic)Shri Thanedar (Democratic)Greg Stanton (Democratic)Al Green (Democratic)Don Bacon (Republican)Nikki Budzinski (Democratic)John B. Larson (Democratic)Hillary J. Scholten (Democratic)Morgan McGarvey (Democratic)Brittany Pettersen (Democratic)Sean Casten (Democratic)William R. Keating (Democratic)Rick Larsen (Democratic)Colin Z. Allred (Democratic)Lori Trahan (Democratic)Nanette Diaz Barragán (Democratic)Jason Crow (Democratic)Teresa Leger Fernandez (Democratic)Chellie Pingree (Democratic)

Health Subcommittee, Judiciary Committee, Energy and Commerce Committee

Health

Related Bills

  • HR 118-4005: Naloxone Affordability Act of 2023
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Civil actions and liabilityCongressional oversightCorrectional facilities and imprisonmentCustoms enforcementDrug, alcohol, tobacco useDrug trafficking and controlled substancesFederal preemptionGovernment information and archivesGovernment studies and investigationsHealth care costs and insuranceHealth care coverage and accessHealth information and medical recordsHealth promotion and preventive careIntelligence activities, surveillance, classified informationIntergovernmental relationsLaw enforcement administration and fundingMedical researchMental healthResearch administration and fundingRetail and wholesale tradesSmuggling and traffickingState and local government operations